Use Your Voice: Pharmacists as Patient Advocates
Drug Topics
AUGUST 6, 2024
From expanding vaccination coverage to battling with PBMs, the community pharmacist has the ability to promote change like never before.
Sat.Aug 03, 2024 - Fri.Aug 09, 2024
205 
Human Pluripotent Stem Cell Line Variability Supports Successful Cortical Organoid Production
Pharmacy Times
AUGUST 5, 2024
Small adjustments in human pluripotent stem cell cultures and the molecule concentration patterns in the initial 5 days of differentiation are essential to “rescue” the lines.
Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Opinion: Noah Lyles’ collapse with Covid: How not to manage health at the Olympics
STAT
AUGUST 9, 2024
Noah Lyles, a 27-year-old from Gainesville, Florida, has had himself quite an Olympics. He won a gold medal in a photo finish in the 100-meter dash on August 4. He went on to win a bronze medal in the 200-meter dash four days later, then collapsed in a heap and needed a wheelchair to get off the track, suggesting that sports officials and team doctors have put athletes’ health last, not first, during the Paris Olympics.
Epic rolls out new feature to make it easier for patients to share medical records with health apps
Fierce Healthcare
AUGUST 4, 2024
Medical records software giant Epic has rolled out a new feature that makes it easier for patients to release their medical records to the health or wellness apps they use. | The new capability is part of a wider effort by the healthcare industry, facilitated by new health tech policies from the federal government, to advance data-sharing at scale.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Healthful Diets Are Crucial, But Population-Level Follow-Through Remains a Challenge
Drug Topics
AUGUST 3, 2024
Health care professionals all agree that a healthy diet is the foundation of cardiovascular and cardiometabolic health, but follow-through on the population level is lacking.
Expert: Psychosis in Alzheimer Disease Contributes to Rapid Cognitive, Functional Decline
Pharmacy Times
AUGUST 3, 2024
In addition to a rapid deterioration, psychosis in Alzheimer disease can also lead to poorer quality of life, damaging patients’ relationships with caregivers, and increases isolation.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Appeals court upholds ruling that struck down surprise billing arbitration process
Fierce Healthcare
AUGUST 6, 2024
A federal appeals court has upheld a lower court decision that struck down key parts of legislation aimed at reforming surprise medical billing. | A federal appeals court upheld a lower court decision that struck down key parts of legislation aimed at reforming surprise medical billing.
Cannabis Use Associated with Increased Risk of Head and Neck Cancer
Drug Topics
AUGUST 9, 2024
A cohort study was conducted to address the association between patients with cannabis-related disorders and their risk of developing head and neck cancer.
Developing Relationships With State Boards of Pharmacy Is Valuable for Pharmacies and Pharmacists
Pharmacy Times
AUGUST 5, 2024
A pharmacy's relationship with its state board(s) of pharmacy is crucial for its operation and success, yet it is often overlooked due to the complex demands on pharmacists and pharmacy owners.
CDC slightly increases risk bird flu could cause a pandemic in latest assessment
STAT
AUGUST 9, 2024
The Centers for Disease Control and Prevention issued a new risk assessment of the H5N1 bird flu virus circulating in dairy cows on Friday, increasing slightly its estimate of the chance it poses of triggering a pandemic. The new assessment , developed using the CDC’s influenza risk assessment tool or IRAT, gauged the risk the virus might someday cause a pandemic at 5.79, up from a previous score of 5.12 from an assessment of a related virus conducted in April 2023.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
BioNTech posts €808M loss as company continues to come to grips with seasonal COVID vaccine market
Fierce Pharma
AUGUST 5, 2024
While Pfizer’s German mRNA partner BioNTech has high hopes for its post-COVID future, the company continues to feel the squeeze from the changeover to a seasonal vaccine market. | While Pfizer’s German mRNA partner BioNTech has high hopes for its post-COVID future, the company continues to feel the squeeze from the changeover to a seasonal vaccine market.
Problematic Opioid Prescribing Among Patients with Chronic Pain
Drug Topics
AUGUST 8, 2024
Researchers conducted a systematic review of literature exploring the misuse of opioid prescriptions for patients with chronic non-cancer pain.
FDA Declines to Approve MDMA for PTSD
Pharmacy Times
AUGUST 9, 2024
Previously, an independent advisory panel for the FDA rejected the use of MDMA-assisted therapy for posttraumatic stress disorder (PTSD), citing concerns of the reliability of the clinical trial data.
STAT+: How UnitedHealth turned a questionable artery-screening program into a gold mine
STAT
AUGUST 7, 2024
The nation’s largest health care company pressed thousands of its clinicians to use a thinly tested medical device to screen people for artery disease, dramatically boosting payments from the federal government for years even though many of the patients were not sick, a STAT investigation found. The result was a torrent of sometimes questionable diagnoses of peripheral artery disease.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
ASTP/ONC proposal would require HHS contractors to use certified health IT tech
Fierce Healthcare
AUGUST 8, 2024
The Department of Health and Human Services’ technology office dropped a new proposed rule on Thursday that would require healthcare entities that contract with HHS to use government-cert | The newly rebranded Office of the Assistant Secretary of Technology Policy released a proposed rule Thursday that could expand the use of government-certified health technology.
Weekend ICYMI: July 29 to August 2
Drug Topics
AUGUST 4, 2024
In case you missed it, this week we had news about CVS in the spotlight of PBM reform, landmark FDA approvals in synovial sarcoma, liraglutide for dementia, and more.
GLP-1 Agonists Show Promise in Treatment of Neurodegenerative Disorders
Pharmacy Times
AUGUST 7, 2024
Significant commonalities between type 2 diabetes and neurodegenerative disorders suggest that treatments effective for one condition may benefit the other.
FDA rejects MDMA as a psychedelic treatment for PTSD
STAT
AUGUST 9, 2024
The Food and Drug Administration rejected MDMA as a treatment for post-traumatic stress disorder on Friday, in a blow to drug activists and veterans who’ve long campaigned for the psychedelic treatment. Although two Phase 3 trials suggested the treatment was effective, strong opposition by an agency scientific advisory committee in June and allegations of missing adverse event data and research bias may have doomed the application by Lykos Therapeutics.
Bavarian Nordic scores $157M contract to replenish US supplies of smallpox/mpox vaccine Jynneos
Fierce Pharma
AUGUST 8, 2024
Following the commercial launch of Bavarian Nordic’s smallpox/mpox vaccine Jynneos earlier this year, the Danish company has locked up yet another supply agreement with the U.S. government. | The Biomedical Advanced Research and Development Authority (BARDA) is handing Bavarian Nordic $156.8 million to “partly replenish” Jynneos vaccine stocks in response to the 2022 outbreak of mpox, the disease formerly known as monkeypox.
Student, Staffing Shortages Continue to Impact Pharmacy Profession
Drug Topics
AUGUST 6, 2024
The COVID-19 pandemic led to increased pharmacist burnout and workforce shortages. The impact is still being felt today.
Experts: Pharmacists Have a Crucial Role in the Treatment of Sarcomas in the Pediatric Setting
Pharmacy Times
AUGUST 7, 2024
Two pediatric oncology pharmacists emphasize pharmacists personalize supportive care, educate patients and their caregivers, advocate for patients, and collaborate with other health care workers.
Harris’ reported running mate, Minnesota Governor Tim Walz, boasts progressive health care record
STAT
AUGUST 6, 2024
WASHINGTON — With Minnesota Gov. Tim Walz as her running mate, Vice President Kamala Harris has tapped a fiery advocate for public health and abortion rights. Harris is said to have chosen Walz as her vice presidential pick as of Tuesday morning, according to multiple news reports, and is expected to officially announce Walz at a rally in Philadelphia, Penn., on Tuesday evening.
Novartis and Viatris sued by estate of Henrietta Lacks, whose cells were extracted for research in 1951
Fierce Pharma
AUGUST 5, 2024
The family of a Baltimore woman whose cells were extracted for medical research without her consent more than 70 years ago has filed another lawsuit against drugmakers that allegedly profited from | The family of a Baltimore woman whose cells were extracted for medical research without her consent more than 70 years ago has filed another lawsuit against drugmakers that allegedly profited from the discoveries they made using her genetic material.
Online Pharmacies Are Illegally Selling GLP-1s Without Prescriptions
Drug Topics
AUGUST 5, 2024
A study found that test products purchased from illegal online pharmacy operations had lower purity levels and significantly more semaglutide content than what was advertised on the label.
FDA Approves First Nasal Spray for Anaphylaxis
Pharmacy Times
AUGUST 9, 2024
neffy is an epinephrine nasal spray for the emergency treatment of allergic reactions in adults and pediatric patients.
As Covid deaths drop, heart disease and cancer remain leading causes of death
STAT
AUGUST 8, 2024
Since its emergence in 2020, Covid has jumbled the list of the 10 leading causes of deaths in the United States. It roared into third place in 2020 but has now fallen to 10th place, the National Center for Health Statistics reported Thursday. Heart disease and cancer remained the first and second leading causes of death, followed by unintentional injuries as No. 3.
Big Health clinches FDA clearance of its digital therapeutic for insomnia, SleepioRx
Fierce Healthcare
AUGUST 8, 2024
Big Health, a maker of digital treatments for mental health, has clinched Food & Drug Administration (FDA) clearance of its product for insomnia, Fierce Healthcare has learned in an a | SleepioRx, its flagship digital therapeutic, is intended for the treatment of chronic insomnia and insomnia disorder as an adjunct to usual care in adults over 18.
The 2024-2025 Flu Season: What to Expect
Drug Topics
AUGUST 9, 2024
The composition of the latest flu vaccine has changed. Here’s what pharmacists need to know.
Intravenous Immunoglobulin Preparations Leads to Varied Effects in Patients With Kawasaki Disease
Pharmacy Times
AUGUST 6, 2024
Two different brands of intravenous immunoglobulin have been investigated, finding Brand P led to significantly longer durations of fever and hospitalization when compared to brand T.
Scientists are starting to uncover how neighborhood can affect the biology of cancer
STAT
AUGUST 8, 2024
Where you live has a relationship to your odds of getting cancer and surviving cancer. Epidemiologists studying this link they see in the data have focused on so-called social determinants of health — poor access to transportation, for example, could make it harder for residents to see a doctor. Places lacking grocery stores with fresh food could mean worse nutrition for locals.
Mayo Clinic taps startup SandboxAQ to study new tech — quantum sensing and AI — for cardiac diagnostics
Fierce Healthcare
AUGUST 8, 2024
Mayo Clinic is partnering with startup SandboxAQ to study a new medical device that uses quantum sensing technology and advanced AI algorithms for rapid diagnosis in cardiac care, such as potential | Mayo Clinic is partnering with startup SandboxAQ to study a new medical device that uses quantum sensing technology and advanced AI algorithms for rapid diagnosis in cardiac care, such as detecting a heart attack.
Servier snags FDA approval for Voranigo, the 1st targeted therapy for a common type of brain tumor
Fierce Pharma
AUGUST 6, 2024
Servier has expanded its IDH drug armamentarium with the FDA approval for an IDH1/2 dual inhibitor. | Servier's Voranigo, or vorasidenib, is now the first systemic therapy for low-grade IDH-mutant brain cancer.
Study Finds Abacavir Increases Cardiovascular Risk in Patients With HIV
Pharmacy Times
AUGUST 7, 2024
Cholesterol-lowering agents, like statins, reduced the risk of major adverse cardiovascular events and cardiovascular disease in patients with HIV.
Millions of people became uninsured as Medicaid programs cut coverage, new data show
STAT
AUGUST 5, 2024
The national uninsured rate rose from 7.7% to 8.2% earlier this year, a result of states booting millions of Americans from their state Medicaid programs, according to new data from the Centers for Disease Control and Prevention. The 7.7% uninsured rate in 2023 was a record low at the time, but didn’t factor in any of the people who were losing their Medicaid coverage.
Let's personalize your content